The present invention is related to prosthetic heart valve replacement, and more particularly to devices, systems, and methods for transcatheter delivery of collapsible prosthetic heart valves.
Prosthetic heart valves that are collapsible to a relatively small circumferential size can be delivered into a patient less invasively than valves that are not collapsible. For example, a collapsible valve may be delivered into a patient via a tube-like delivery apparatus such as a catheter, a trocar, a laparoscopic instrument, or the like. This collapsibility can avoid the need for a more invasive procedure such as full open-chest, open-heart surgery.
Collapsible prosthetic heart valves typically take the form of a valve structure mounted on a stent. There are two types of stents on which the valve structures are ordinarily mounted: a self-expanding stent and a balloon-expandable stent. To place such valves into a delivery apparatus and ultimately into a patient, the valve must first be collapsed or crimped to reduce its circumferential size.
When a collapsed prosthetic valve has reached the desired implant site in the patient (e.g., at or near the annulus of the patient's heart valve that is to be replaced by the prosthetic valve), the prosthetic valve can be deployed or released from the delivery apparatus and re-expanded to full operating size. For balloon-expandable valves, this generally involves releasing the entire valve, assuring its proper location, and then expanding a balloon positioned within the valve stent. For self-expanding valves, on the other hand, the stent automatically expands as the sheath covering the valve is withdrawn.
In conventional delivery systems for self-expanding aortic valves, for example, after the delivery system has been positioned for deployment, the annulus end of the valve is typically unsheathed and expanded first, while the aortic end of the valve remains sheathed. Once the annulus end of the valve has expanded, it may be determined that the valve needs to be repositioned in the patient's aortic annulus. To accomplish this, a user (such as a surgeon or an interventional cardiologist) typically resheathes the annulus end of the valve, so that the valve can be repositioned while in a collapsed state. After the valve has been repositioned, the surgeon can again release the valve.
Once a self-expanding valve has been fully deployed, it expands to a diameter larger than that of the sheath that previously contained the valve in the collapsed condition, making resheathing impossible, or difficult at best. In order for the user to be able to resheathe a partially-deployed valve, a portion of the valve must still be collapsed inside of the sheath.
Despite the various improvements that have been made to the collapsible prosthetic heart valve delivery process, conventional delivery devices, systems, and methods suffer from some shortcomings. For example, in conventional delivery devices for self-expanding valves, it is difficult to control how much of the valve remains in the sheath during a partial deployment, and the user may accidentally deploy the valve fully before verifying that the annulus end of the valve is in the optimal position in the patient's valve annulus, thereby taking away the opportunity to resheathe and reposition the valve.
There therefore is a need for further improvements to the devices, systems, and methods for transcatheter delivery of collapsible prosthetic heart valves, and in particular, self-expanding prosthetic heart valves. Among other advantages, the present invention may address one or more of these needs.
A delivery device for a collapsible prosthetic heart valve, a system for delivery of a collapsible prosthetic heart valve, and a method of delivering a collapsible prosthetic heart valve in a patient are disclosed.
A delivery device for a collapsible prosthetic heart valve includes an operating handle, including a frame defining a movement space therein, a carriage assembly moveable in a longitudinal direction within the movement space, and a first resheathing lock having a locked position and an unlocked position, the first resheathing lock in the locked position limiting movement of the carriage assembly in the longitudinal direction to a first intermediate position in the movement space, and the first resheathing lock in the unlocked position permitting movement of the carriage assembly in the longitudinal direction beyond the first intermediate position in the movement space. The delivery device also includes a catheter assembly, including a first shaft around which a compartment is defined, the first shaft being fixedly connected to one of the frame or the carriage assembly, the compartment being adapted to receive the valve in an assembled condition, and a distal sheath operatively connected to the carriage assembly, the distal sheath being moveable between a closed condition adapted to maintain the valve in the assembled condition and an open condition adapted to fully deploy the valve, wherein movement of the carriage assembly to the first intermediate position moves the distal sheath to a condition between the closed condition and the open condition so that the valve is not fully deployed.
The first shaft may be fixedly connected to the frame, the catheter assembly further including an outer shaft connecting the carriage assembly to the distal sheath and at least partially surrounding the first shaft. The first shaft may be fixedly connected to the carriage assembly, and the catheter assembly may further include an outer shaft connecting the frame to the compartment and at least partially surrounding the first shaft. The operating handle may further include a deployment lock moveable between a locked position and an unlocked position, the deployment lock in the locked position preventing movement of the carriage assembly in the longitudinal direction within the movement space, the deployment lock in the unlocked position permitting movement of the carriage assembly in the longitudinal direction within the movement space. The carriage assembly may include a threaded rod and the operating handle may further include a deployment actuator threadedly engaged with the threaded rod such that rotation of the deployment actuator moves the carriage assembly in the longitudinal direction in the movement space.
The compartment may define a first length and the first intermediate position in the movement space may correspond to a travel distance of the carriage assembly, the travel distance being less than the first length. The collapsible prosthetic heart valve may define a second length and the travel distance may be about 80% to about 90% of the second length. The operating handle may further include a second resheathing lock moveable between a locked position and an unlocked position, the second resheathing lock in the locked position limiting movement of the carriage assembly in the longitudinal direction to a second intermediate position in the movement space, the second resheathing lock in the unlocked position permitting movement of the carriage assembly in the longitudinal direction beyond the second intermediate position. The collapsible prosthetic heart valve may define a length, the second intermediate position may define a first travel distance, and the first intermediate position may define a second travel distance, the first travel distance being about 40% to about 60% of the length and the second travel distance being about 80% to about 90% of the length. The frame may include a slot and the first resheathing lock may include a retractable locking member that is engaged in the slot when the first resheathing lock is in the locked position, an end of the slot defining the first intermediate position.
A system for delivery of a collapsible prosthetic heart valve includes a collapsible prosthetic heart valve, and an operating handle, including a frame defining a movement space therein, a carriage assembly moveable in a longitudinal direction within the movement space, and a first resheathing lock having a locked position and an unlocked position, the resheathing lock in the locked position limiting movement of the carriage assembly in the longitudinal direction to a first intermediate position in the movement space, and the first resheathing lock in the unlocked position permitting movement of the carriage assembly in the longitudinal direction beyond the first intermediate position in the movement space. The system also includes a catheter assembly, including a first shaft around which a compartment is defined, the first shaft being fixedly connected to one of the frame or the carriage assembly, the valve being mounted in the compartment in an assembled condition, and a distal sheath operatively connected to the carriage assembly, the distal sheath being moveable between a closed condition adapted to maintain the valve in the assembled condition and an open condition adapted to fully deploy the valve, wherein movement of the carriage assembly to the first intermediate position moves the distal sheath to a condition between the closed condition and the open condition so that the valve is not fully deployed.
The collapsible prosthetic heart valve may define a length and the first intermediate position in the movement space may correspond to a travel distance of the carriage assembly, the travel distance being about 80% to about 90% of the length. The operating handle may further include a second resheathing lock moveable between a locked position and an unlocked position, the second resheathing lock in the locked position limiting movement of the carriage assembly in the longitudinal direction to a second intermediate position in the movement space, the second resheathing lock in the unlocked position permitting movement of the carriage assembly in the longitudinal direction beyond the second intermediate position. The collapsible prosthetic heart valve may define a length, the second intermediate position may define a first travel distance, and the first intermediate position may define a second travel distance, the first travel distance being about 40% to about 60% of the length and the second travel distance being about 80% to about 90% of the length.
A method of delivering a collapsible prosthetic heart valve in a patient includes providing a delivery device having a catheter assembly and an operating handle, the catheter assembly including a compartment adapted to receive the valve in an assembled condition, the operating handle including a frame defining a movement space therein, a carriage assembly moveable in a longitudinal direction within the movement space, and a resheathing lock having a locked position limiting movement of the carriage assembly in the longitudinal direction to a first intermediate position in the movement space and an unlocked position permitting movement of the carriage assembly in the longitudinal direction beyond the first intermediate position in the movement space. The method also includes loading the valve into the compartment of the catheter assembly, the compartment and the valve being covered by a distal sheath of the catheter assembly, inserting the catheter assembly into the patient, positioning the valve at a target location within the patient, using the operating handle to partially deploy the valve by moving the carriage assembly in the longitudinal direction to the first intermediate position in the movement space, moving the resheathing lock from the locked position to the unlocked position, and using the operating handle to fully deploy the valve by moving the carriage assembly in the longitudinal direction beyond the first intermediate position in the movement space.
The target location within the patient may be the native aortic annulus of the patient. The distal sheath of the delivery device may be inserted through a femoral artery of the patient. The distal sheath of the delivery device may be inserted through the apex of the heart of the patient. The step of using an operating handle to partially deploy the valve may include rotating a deployment actuator to move the carriage assembly in the longitudinal direction. The method may also include unlocking a deployment lock to release the carriage assembly for movement in the longitudinal direction. The valve may define a length, the intermediate position may define a longitudinal travel distance, and the step of using an operating handle to partially deploy the valve may include moving the carriage assembly through the travel distance, the travel distance being about 80% to about 90% of the length of the valve.
Various embodiments of the present invention will now be described with reference to the appended drawings. It is appreciated that these drawings depict only some embodiments of the invention and are therefore not to be considered limiting of its scope.
As used herein, the terms “proximal” and “distal” are to be taken as relative to a user using the disclosed delivery devices. “Proximal” is to be understood as relatively close to the user and “distal” is to be understood as relatively farther away from the user.
Referring now to
The inner shaft 26 extends through the operating handle 20 to the distal tip 14 of the delivery device, and includes a retainer 25 affixed thereto at a spaced distance from distal tip 14 and adapted to hold a collapsible prosthetic valve in the compartment 23.
The distal sheath 24 surrounds the inner shaft 26 and is slidable relative to the inner shaft such that it can selectively cover or uncover the compartment 23. The distal sheath 24 is affixed at its proximal end to an outer shaft 22, the proximal end of which is connected to the operating handle 20 in a manner to be described. The distal end 27 of the distal sheath 24 abuts the distal tip 14 when the distal sheath is fully covering the compartment 23, and is spaced apart from the distal tip 14 when the compartment 23 is at least partially uncovered.
The operating handle 20 is adapted to control deployment of a prosthetic valve located in the compartment 23 by permitting a user to selectively slide the outer shaft 22 proximally or distally relative to the inner shaft 26, thereby respectively uncovering or covering the compartment with the distal sheath 24. The proximal end of the inner shaft 26 is affixed to an outer frame 30 of the operating handle 20, and the proximal end of the outer shaft 22 is affixed to a carriage assembly 40 of the operating handle that is slidable along a longitudinal axis of the frame, such that a user can selectively slide the outer shaft relative to the inner shaft by sliding the carriage assembly relative to the frame.
A hemostasis valve 28 (shown, for example, in
The frame 30 includes a pair of side rails 31 joined at the proximal end 12 by a proximal end member 32 and joined at the distal end by a distal end member 33. Collectively, the side rails 31, the end member 32, and the end member 33 define an elongated space 34 in the frame 30 in which the carriage assembly 40 may travel. The elongated space 34 preferably permits the carriage assembly 40 to travel a distance that is at least as long as the anticipated length of the prosthetic valve to be delivered (e.g., at least about 50 mm), such that the distal sheath 24 can be fully retracted off of the prosthetic valve. An enlarged bore 35 in the end member 33 is sized to freely and slidingly receive a threaded rod 36 (shown in
The carriage assembly 40 includes a main body 41 and the threaded rod 36 extending distally therefrom along the longitudinal axis of the outer frame 30. The threaded rod 36 preferably is longer than the anticipated maximum travel distance of the carriage assembly 40 within the elongated space 34 (e.g., at least about 50 mm), such that the threaded rod 36 does not fully withdraw from the enlarged bore 35 during deployment of the prosthetic valve.
A deployment actuator 21 is threadedly engaged with the threaded rod 36. The deployment actuator is positioned in abutting relationship with the end member 33 of the frame 30 so that rotation of the actuator in one direction (either clockwise or counterclockwise depending on the orientation of the threads on the threaded rod 36) causes the threaded rod and the carriage assembly 40 to move proximally within the elongated space 34. Rotation of the deployment actuator 21 in the opposite direction, however, does not cause translational movement of carriage assembly 40, but rather simply causes the deployment actuator to threadedly advance on the threaded rod 36 as it moves away from the end member 33 of the frame 30. Although the movement of the deployment actuator 21 away from the end member 33 of the frame 30 enables the carriage assembly 40 to move distally until the deployment actuator again contacts the distal end member 33 of the frame, such movement is not easily controllable, but rather is subject to the “touch and feel” of the user.
In a variant of the embodiment described above, the deployment actuator 21 may be longitudinally constrained relative to the frame 30, for example, by the engagement of an annular rib on the distal end of the deployment actuator with an annular groove in the bore 35 so that the deployment actuator 21 may rotate in either direction without moving away from the distal end member 33 of the frame. Rather than an annular rib and an annular groove, any mechanism may be used for longitudinally fixing the deployment actuator 21 relative to the distal end 33 of the frame 30 so as to permit rotation of the deployment actuator in both directions without translation of same within the space 34. Such an arrangement would provide a user with the ability to carefully control movement of the carriage assembly 40 both proximally within the space 34 during a valve deployment operation, and distally within the space 34 during a resheathing operation, as described more fully below.
Referring now to
The carriage assembly 40 also includes a resheathing lock 44 adapted to limit the longitudinal movement of the carriage assembly within the outer frame 30, thereby preventing a user from accidentally completing the deployment of a prosthetic valve. The resheathing lock 44 includes a control member 50 that is longitudinally slidable in a slot 46 between a distal position (shown in
The slot 38 has a length L1 between the distal end 38′ and the proximal end 38″ that is slightly greater than the initial distance that the carriage assembly 40 may travel while still permitting resheathing of the valve contained in the compartment 23. More particularly, the length L1 is equal to this initial travel distance plus the diameter of the pin 55. As a result, when the resheathing lock 44 is in the locked position, the carriage assembly 40 can move proximally relative to the frame 30 only by this amount.
The initial distance that the carriage assembly 40 can travel before being limited by the proximal end 38″ of the slot 38 may depend on the structure of the particular prosthetic valve to be deployed. Preferably, the initial travel distance of the carriage assembly 40 is about 3 mm to about 5 mm less than the crimped valve length. Alternatively, the initial travel distance of the carriage assembly 40 may be about 40 mm to about 45 mm, which is about 80% to about 90% of the length of an exemplary 50 mm valve. In other arrangements, the initial distance that the carriage assembly 40 can travel and/or the length of the slot 38 can be determined as a percentage of the length of the prosthetic valve and/or of the compartment 23, including, for example, 50%, 60%, 70%, 75%, 85%, or 95%.
The operation of the delivery device 10 to deploy a prosthetic valve will now be described. To load the delivery device 10 with a collapsible prosthetic valve, a user can retract the distal sheath 24 to expose the compartment 23, place the valve around the inner shaft 26, couple the proximal end of the valve to the retainer 25, compresses or crimp the valve, and slide the distal sheath 24 back over the compartment, which holds the valve in a compressed state. In this starting condition, the handle 20 will be in an initial state with the carriage assembly 40 at its distalmost position within the frame 30, the deployment lock 43 will be in its locked position to prevent accidental deployment, and the resheathing lock 44 will be in its locked position to prevent full deployment once the deployment lock 43 has been unlocked.
To use the operating handle 20 to deploy a prosthetic valve that has been compressed and inserted in the compartment 23 and covered by the distal sheath 24, a user will initially move the deployment lock 43 to its unlocked position, thereby freeing the carriage assembly 40 for longitudinal movement. The user can then rotate the deployment actuator 21, causing the carriage assembly 40 to slide proximally within the elongated space 34 in frame 30. Because the distal sheath 24 is affixed to the outer shaft 22, which in turn is affixed to the carriage assembly 40, and because the inner shaft 26 is affixed to the frame 30, sliding the carriage assembly proximally relative to the frame will retract the distal sheath proximally from the compartment 23, thereby exposing and initiating deployment of the valve located therein.
It will be appreciated that the user can initiate the deployment process without use of the deployment actuator 21 by simply grasping the carriage assembly 40 and pulling same proximally within the frame 30. Such action requires significant pulling force in order to overcome the frictional forces acting on the outer shaft 22 and the distal sheath 24. For that reason, the use of the deployment actuator 21 to retract the distal sheath 24 is preferred since such use provides the user with a mechanical advantage to overcome the aforementioned frictional forces, thereby providing the user with much greater control of the deployment process.
In any event, since the resheathing lock 44 is in the locked position, movement of the carriage assembly 40 proximally may continue only until the pin 55 of the locking member 52 contacts the proximal end 38″ of the slot 38. At this point, the distal sheath 24 will not be fully withdrawn from the compartment 23, and the prosthetic valve will not be fully deployed.
When the deployment procedure has reached this juncture, the user can evaluate the position of the valve and determine whether the annulus end of the valve is properly aligned relative to the patient's aortic annulus. If repositioning is desired, the user may resheathe the valve by sliding the carriage assembly 40 distally within the frame 30, thereby moving the distal sheath 24 distally over the compartment 23 and the partially deployed valve and recollapsing the expanded part of the stent portion of the valve. This may be accomplished by rotating the deployment actuator 21 to advance it proximally on the threaded rod 36 and simply pushing the carriage assembly 40 in the distal direction or, in the variant embodiment in which the deployment actuator 21 is longitudinally fixed relative to the distal end member 33 of the frame 30, by rotating the deployment actuator in the direction opposite that used for deployment. Such rotation will cause the threaded rod 36 to progress distally through the deployment actuator 21 until the carriage assembly 40 has reached the starting condition shown in
Once the valve has been properly positioned relative to the aortic annulus, the user may complete the deployment process. To do so, the user slides the resheathing lock 44 from the locked position to the unlocked position, thereby retracting the pin 55 of locking member 52 so that the carriage assembly 40 is free to continue its movement proximally within the frame 30. The user can complete the deployment of the valve by continuing to slide the carriage assembly 40 proximally, for example, by rotating the deployment actuator 21. When the valve has been unsheathed, the stent portion of the valve self-expands and disengages from the retainer 25, thereby releasing the valve from the catheter assembly 16.
Referring now to
The frame 30a of the operating handle 20a is similar to the frame 30 shown in
The valve deployment process using the operating handle 20a is similar to the deployment process described above in connection with the operating handle 20, except for the use of the second resheathing lock 44a. Thus, to use the operating handle 20a to deploy a prosthetic valve from compartment 23 of the catheter assembly 16, the user can first move the deployment lock 43 to an unlocked position, thereby freeing carriage assembly 40a for proximal movement relative to the frame 30a. With the deployment lock 43 in the unlocked position, the user can rotate the deployment actuator 21 to move the carriage assembly 40a proximally until the lateral pin 55a of resheathing lock 44a contacts the proximal end 38a″ of the second resheathing slot 38a.
At this stage of deployment, while the second resheathing lock 44a is in the locked position, the user can decide to resheathe and reposition the valve. At about the halfway-unsheathed position, the valve may be partially functioning, such that the user can assess the valve position and decide whether to continue deployment or to resheathe and reposition the valve. If the position of the valve appears to be acceptable, the user can continue to the next stage of deployment by moving the second resheathing lock 44a to the unlocked position, freeing the carriage assembly 40a for further proximal movement within the frame 30a.
With the second resheathing lock 44a unlocked, the user can continue to rotate the deployment actuator 21 to further move the carriage assembly 40a proximally. However, since the resheathing lock 44 is in the locked position, the proximal movement of the carriage assembly 40a may continue only until the pin 55 of the locking member 52 contacts the proximal end 38″ of the slot 38. At this point, the distal sheath 24 will not be fully withdrawn from the compartment 23, and the prosthetic valve will still not be fully deployed. Once again, the user may evaluate the position of the valve and determine whether repositioning is necessary. If repositioning is desired, the user may resheathe the valve by sliding the carriage assembly 40a distally within the frame 30a in the manner described above. On the other hand, if the valve position is acceptable, the user may unlock the resheathing lock 44 and complete the deployment of the valve by continuing to slide the carriage assembly 40a proximally, such as by rotating the deployment actuator 21.
Referring now to
The operating handle 120 includes a carriage assembly 140 having a resheathing lock 144 that controls the lateral retraction of a locking pin 155. The resheathing lock 144 includes a cam member 160 that is slidably mounted in an elongated slot 146. The cam member 160 has a tapered surface 161, such that when the cam member is slid proximally in the slot 146, the locking pin 155 retracts in a lateral direction out of the slot 138, thereby permitting the carriage assembly 140 to continue proximally past the limit set by the proximal end of slot 138 and enabling the valve to be fully deployed.
Although the retraction mechanism for the locking pin 155 is not shown in
Although a deployment locking mechanism is not shown in
Referring now to
Rather than having a resheathing lock mechanism that includes a slot that is closed on both ends, such as the slot 38 described above in connection with the operating handle 20, the operating handle 120a has a frame 130a that includes a protuberance 139 that defines the proximal end of a recess 138a that is open on the distal end. The protuberance 139 is positioned on the frame 130a in substantially the same position as the proximal end 38″ of the slot 38 is positioned in the operating handle 20.
During staged deployment of a prosthetic valve, when the locking pin 155 contacts the protuberance 139, the proximal movement of the carriage assembly 140 is stopped. While the resheathing lock 144 is in the locked position (shown in
Referring now to
Rather than having a resheathing lock that includes a slot that is closed on both ends, such as the slot 38 described above in connection with the operating handle 20, or a recess that is closed on one end, such as the recess 138a described above in connection with the operating handle 120a, the operating handle 120b includes a carriage assembly 140b and a resheathing lock member 155b that projects through the side rail 131b of the frame 130b and into the elongated space 134 so as to obstruct the path of travel of the carriage assembly 140b in the proximal direction. As such, the resheathing lock member 155b defines the initial distance that the carriage assembly 140b may travel before full deployment of the valve occurs. The resheathing lock member 155b may be moved to an unlocked position by retracting the lock member by a sufficient amount that it no longer protrudes into the space 134. With the resheathing lock member 155b in the unlocked position, the carriage assembly 140b may continue to move proximally, thereby allowing for full deployment of the valve. Optionally, the locking member 155b may be designed to be fully removable from the frame 130b and disposable.
Referring now to
The support shaft 221 extends between a pair of spaced retainers 225 and 227 affixed thereto and defining the ends of the compartment 223. A collapsible prosthetic valve may be assembled around the support shaft 221 and between the retainers 225 and 227 in the compartment 223.
The distal sheath 224 surrounds the support shaft 221 and is slidable relative to the support shaft such that it can selectively cover or uncover the compartment 223. The distal sheath 224 is affixed at its distal end to the distal tip 214, and its proximal end 229 abuts the retainer 227 when the distal sheath is fully covering the compartment 223, as shown in
The delivery device further includes an outer shaft 222, the proximal end of which is connected to the operating handle 220, and the distal end of which is connected to the retainer 227. An inner shaft 226 extends through the operating handle 220 and the support shaft 221 to the distal tip 214. The connection of the distal sheath 224 to the distal tip 214 thus enables the inner shaft 226 to control the movement of the distal sheath both proximally and distally.
The operating handle 220 is adapted to control deployment of a prosthetic valve located in the compartment 223 by permitting a user to selectively slide the inner shaft 226 and the attached distal sheath 224 distally or proximally relative to the support shaft 221, thereby respectively uncovering or covering the compartment with the distal sheath. The proximal end of the outer shaft 222 is affixed to an outer frame 230 of the operating handle 220, and the proximal end of the inner shaft 226 is affixed to a carriage assembly 240 of the operating handle that is slidable along a longitudinal axis of the frame, such that a user can selectively slide the inner shaft relative to the outer shaft by sliding the carriage assembly relative to the frame. A hemostasis valve 228 provides an internal gasket adapted to create a seal between the inner shaft 226 and the proximal end of the outer shaft 222. The strength of this seal may be adjusted by a gasket adjustment wheel 242 that functions in substantially the same manner as the adjustment wheel 42 described above.
The frame 230 includes a pair of side rails 231 joined at the proximal end 212 by an end member 232 and joined at the distal end by an end member 233. Collectively, the side rails 231, the end member 232, and the end member 233 define an elongated space 234 in the frame 230 in which the carriage assembly 240 may travel.
The carriage assembly 240 is shown in
The operating handle 220 may also include one or more lock mechanisms adapted to prevent accidental partial or full deployment of a prosthetic valve located in the compartment 223. Thus, as with all of the operating handles described above, the operating handle 220 may include a deployment lock for preventing a user from accidentally initiating deployment of a valve, as well as a resheathing lock for preventing the user from accidentally completing deployment of the valve. The structures of these lock mechanisms may be similar to the structures of any of the lock mechanisms described above, but modified to limit the movement of the carriage assembly 240 distally relative to the frame 230. For example, the lock mechanism may be similar to that included in the operating handle 120b shown and described with reference to
The operation of the operating handle 220 to deploy a prosthetic valve from the compartment 223 is similar to the operation of the operating handle 20 described above with reference to
Since the resheathing lock member 255 is in the locked position, movement of the carriage assembly 240 distally may continue only until the distal end of the carriage assembly contacts the lock member. At this juncture, the distal sheath 224 will not fully uncover the compartment 223, and the prosthetic valve will not be fully deployed. Therefore, if the user desires to resheathe and reposition the valve before full deployment, the user can do so by grasping the carriage assembly 240 and sliding it proximally within the frame 230 until the carriage assembly contacts the proximal end 232 of the frame. Once the valve has been properly positioned, the deployment operation may be completed by withdrawing the resheathing lock member 255 to the unlocked position and moving the carriage assembly 240 further distally until the valve is fully deployed.
Although the operating handles have been described herein as having one or two resheathing locks, any number of resheathing locks may be used, with or without a deployment lock, resulting in any number of stages in the deployment process. For example, there may be three, four, five, six or more resheathing locks, which thus enable the deployment procedure to be controlled incrementally.
More particularly, if a user desires, for example, a two-stage deployment process, a single resheathing lock may be used, resulting in an unsheathing of perhaps about 80% to about 90% of the valve in a first deployment stage, followed by an unsheathing of the remaining about 10% to about 20% of the valve in a second deployment stage.
If the user desires a three-stage deployment process, on the other hand, a single resheathing lock may be used with a deployment lock, resulting in a first deployment stage in which no deployment can occur, a second deployment stage in which, for example, about 80% to about 90% of the valve is unsheathed, and a third deployment stage in which the remaining about 10% to about 20% of the valve is unsheathed.
Still further, if the user desires a four-stage deployment process, two resheathing locks may be used with a deployment lock, resulting in a first deployment stage in which no deployment can occur, a second deployment stage in which, for example, about 50% of the valve is unsheathed, a third deployment stage in which, for example, about 80% to about 90% of the valve is unsheathed, and a fourth deployment stage in which the remaining about 10% to about 20% of the valve is unsheathed. This last process may be modified to a three-stage deployment process by omitting the deployment lock while keeping the two resheathing locks.
Although the invention herein has been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit and scope of the present invention as defined by the appended claims.
It will be appreciated that the various dependent claims and the features set forth therein can be combined in different ways than presented in the initial claims. It will also be appreciated that the features described in connection with individual embodiments may be shared with others of the described embodiments.
The present application is a continuation of U.S. patent application Ser. No. 14/269,684, filed May 5, 2014, which is a divisional of U.S. patent application Ser. No. 13/212,442, filed Aug. 18, 2011, now U.S. Pat. No. 8,814,931, which claims the benefit of the filing date of U.S. Provisional Patent Application No. 61/376,425, filed Aug. 24, 2010, the disclosures of which are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3657744 | Ersek | Apr 1972 | A |
4275469 | Gabbay | Jun 1981 | A |
4423730 | Gabbay | Jan 1984 | A |
4491986 | Gabbay | Jan 1985 | A |
4759758 | Gabbay | Jul 1988 | A |
4922905 | Strecker | May 1990 | A |
5391172 | Williams et al. | Feb 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5456667 | Ham et al. | Oct 1995 | A |
5480423 | Ravenscroft et al. | Jan 1996 | A |
5843167 | Dwyer et al. | Dec 1998 | A |
5924424 | Stevens et al. | Jul 1999 | A |
5935163 | Gabbay | Aug 1999 | A |
5961549 | Nguyen et al. | Oct 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6083257 | Taylor et al. | Jul 2000 | A |
6090140 | Gabbay | Jul 2000 | A |
6214036 | Letendre et al. | Apr 2001 | B1 |
6264691 | Gabbay | Jul 2001 | B1 |
6267783 | Letendre et al. | Jul 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6368348 | Gabbay | Apr 2002 | B1 |
6419695 | Gabbay | Jul 2002 | B1 |
6488702 | Besselink | Dec 2002 | B1 |
6514261 | Randall et al. | Feb 2003 | B1 |
6517576 | Gabbay | Feb 2003 | B2 |
6533810 | Hankh et al. | Mar 2003 | B2 |
6582464 | Gabbay | Jun 2003 | B2 |
6610088 | Gabbay | Aug 2003 | B1 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6685625 | Gabbay | Feb 2004 | B2 |
6719789 | Cox | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6736845 | Marquez et al. | May 2004 | B2 |
6783556 | Gabbay | Aug 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6814746 | Thompson et al. | Nov 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6869444 | Gabbay | Mar 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7025780 | Gabbay | Apr 2006 | B2 |
7137184 | Schreck | Nov 2006 | B2 |
7160322 | Gabbay | Jan 2007 | B2 |
7247167 | Gabbay | Jul 2007 | B2 |
7267686 | DiMatteo et al. | Sep 2007 | B2 |
7311730 | Gabbay | Dec 2007 | B2 |
7326236 | Andreas et al. | Feb 2008 | B2 |
7329278 | Seguin et al. | Feb 2008 | B2 |
7374573 | Gabbay | May 2008 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7399315 | Iobbi | Jul 2008 | B2 |
7419501 | Chiu et al. | Sep 2008 | B2 |
7452371 | Pavcnik et al. | Nov 2008 | B2 |
7476244 | Buzzard et al. | Jan 2009 | B2 |
7510572 | Gabbay | Mar 2009 | B2 |
RE40816 | Taylor et al. | Jun 2009 | E |
7585321 | Cribier | Sep 2009 | B2 |
7682390 | Seguin | Mar 2010 | B2 |
7731742 | Schlick et al. | Jun 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7846203 | Cribier | Dec 2010 | B2 |
7846204 | Letac et al. | Dec 2010 | B2 |
7914569 | Nguyen et al. | Mar 2011 | B2 |
7967829 | Gunderson et al. | Jun 2011 | B2 |
7993384 | Wu et al. | Aug 2011 | B2 |
8043353 | Kaufmann et al. | Oct 2011 | B2 |
D648854 | Braido | Nov 2011 | S |
D652926 | Braido | Jan 2012 | S |
D652927 | Braido et al. | Jan 2012 | S |
D653341 | Braido et al. | Jan 2012 | S |
D653342 | Braido et al. | Jan 2012 | S |
D653343 | Ness et al. | Jan 2012 | S |
D654169 | Braido | Feb 2012 | S |
D654170 | Braido et al. | Feb 2012 | S |
8353955 | Styrc et al. | Jan 2013 | B2 |
8562663 | Mearns et al. | Oct 2013 | B2 |
8568475 | Nguyen et al. | Oct 2013 | B2 |
8778019 | Knippel et al. | Jul 2014 | B2 |
8790386 | Dwork | Jul 2014 | B2 |
8814931 | Wang et al. | Aug 2014 | B2 |
20020036220 | Gabbay | Mar 2002 | A1 |
20020183827 | Derus et al. | Dec 2002 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030130726 | Thorpe et al. | Jul 2003 | A1 |
20030144725 | Lombardi | Jul 2003 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040049262 | Obermiller et al. | Mar 2004 | A1 |
20040093075 | Kuehne | May 2004 | A1 |
20040148009 | Buzzard et al. | Jul 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040260390 | Sarac et al. | Dec 2004 | A1 |
20050004583 | Oz et al. | Jan 2005 | A1 |
20050027305 | Shiu et al. | Feb 2005 | A1 |
20050049667 | Arbefeuille et al. | Mar 2005 | A1 |
20050080476 | Gunderson et al. | Apr 2005 | A1 |
20050096726 | Sequin et al. | May 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137697 | Salahieh et al. | Jun 2005 | A1 |
20050149159 | Andreas et al. | Jul 2005 | A1 |
20050240254 | Austin | Oct 2005 | A1 |
20050256566 | Gabbay | Nov 2005 | A1 |
20060008497 | Gabbay | Jan 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060106415 | Gabbay | May 2006 | A1 |
20060122692 | Gilad et al. | Jun 2006 | A1 |
20060142848 | Gabbay | Jun 2006 | A1 |
20060167468 | Gabbay | Jul 2006 | A1 |
20060173532 | Flagle et al. | Aug 2006 | A1 |
20060206202 | Bonhoeffer et al. | Sep 2006 | A1 |
20060241744 | Beith | Oct 2006 | A1 |
20060259120 | Vongphakdy et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060276813 | Greenberg | Dec 2006 | A1 |
20060282150 | Olson et al. | Dec 2006 | A1 |
20060282157 | Hill et al. | Dec 2006 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070027534 | Bergheim et al. | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070055358 | Krolik et al. | Mar 2007 | A1 |
20070067029 | Gabbay | Mar 2007 | A1 |
20070073391 | Bourang et al. | Mar 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070093890 | Eliasen et al. | Apr 2007 | A1 |
20070100435 | Case et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070156225 | George et al. | Jul 2007 | A1 |
20070162100 | Gabbay | Jul 2007 | A1 |
20070168013 | Douglas | Jul 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070239271 | Nguyen | Oct 2007 | A1 |
20070244545 | Birdsall et al. | Oct 2007 | A1 |
20070244552 | Salahieh et al. | Oct 2007 | A1 |
20070260301 | Chuter et al. | Nov 2007 | A1 |
20070288087 | Fearnot et al. | Dec 2007 | A1 |
20080004688 | Spenser et al. | Jan 2008 | A1 |
20080009940 | Cribier | Jan 2008 | A1 |
20080021552 | Gabbay | Jan 2008 | A1 |
20080039934 | Styrc | Feb 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082159 | Tseng et al. | Apr 2008 | A1 |
20080097595 | Gabbay | Apr 2008 | A1 |
20080114452 | Gabbay | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080147179 | Cai et al. | Jun 2008 | A1 |
20080147182 | Righini et al. | Jun 2008 | A1 |
20080147183 | Styrc | Jun 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080228264 | Li et al. | Sep 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080255662 | Stacchino et al. | Oct 2008 | A1 |
20080262602 | Wilk et al. | Oct 2008 | A1 |
20080269878 | Iobbi | Oct 2008 | A1 |
20080269879 | Sathe et al. | Oct 2008 | A1 |
20090024137 | Chuter et al. | Jan 2009 | A1 |
20090054975 | del Nido et al. | Feb 2009 | A1 |
20090105798 | Koch | Apr 2009 | A1 |
20090112309 | Jaramillo et al. | Apr 2009 | A1 |
20090118826 | Khaghani | May 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20100004740 | Seguin et al. | Jan 2010 | A1 |
20100036484 | Hariton et al. | Feb 2010 | A1 |
20100049306 | House et al. | Feb 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100087907 | Lattouf | Apr 2010 | A1 |
20100114305 | Kang et al. | May 2010 | A1 |
20100121434 | Paul et al. | May 2010 | A1 |
20100131055 | Case et al. | May 2010 | A1 |
20100168778 | Braido | Jul 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20100174290 | Wuebbeling et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20100204785 | Alkhatib | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249911 | Alkhatib | Sep 2010 | A1 |
20100249923 | Alkhatib et al. | Sep 2010 | A1 |
20100286768 | Alkhatib | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20110029072 | Gabbay | Feb 2011 | A1 |
20110208298 | Tuval et al. | Aug 2011 | A1 |
20110224678 | Gabbay | Sep 2011 | A1 |
20110282425 | Dwork | Nov 2011 | A1 |
20110288626 | Straubinger et al. | Nov 2011 | A1 |
20110295216 | Miller | Dec 2011 | A1 |
20120022635 | Yamashita | Jan 2012 | A1 |
20120053574 | Murray, III et al. | Mar 2012 | A1 |
20120078352 | Wang et al. | Mar 2012 | A1 |
20120197391 | Alkhatib et al. | Aug 2012 | A1 |
20120310332 | Murray et al. | Dec 2012 | A1 |
20130030520 | Lee et al. | Jan 2013 | A1 |
20130138118 | Doyle | May 2013 | A1 |
20130231735 | Deem et al. | Sep 2013 | A1 |
20130304179 | Bialas et al. | Nov 2013 | A1 |
20140067050 | Costello et al. | Mar 2014 | A1 |
20140135909 | Carr et al. | May 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20150305867 | Liu et al. | Oct 2015 | A1 |
20170056169 | Johnson et al. | Mar 2017 | A1 |
Number | Date | Country |
---|---|---|
2011202175 | Jul 2011 | AU |
19857887 | Jul 2000 | DE |
20000659 | May 2001 | DE |
10121210 | Nov 2002 | DE |
202008009610 | Dec 2008 | DE |
0850607 | Jul 1998 | EP |
1000590 | May 2000 | EP |
1129744 | Sep 2001 | EP |
1157673 | Nov 2001 | EP |
1360942 | Nov 2003 | EP |
1584306 | Oct 2005 | EP |
1598031 | Nov 2005 | EP |
2847800 | Oct 2005 | FR |
2001504717 | Apr 2001 | JP |
2003334254 | Nov 2003 | JP |
2004130074 | Apr 2004 | JP |
2010504820 | Feb 2010 | JP |
2010526609 | Aug 2010 | JP |
2010531193 | Sep 2010 | JP |
2012500665 | Jan 2012 | JP |
9117720 | Nov 1991 | WO |
9716133 | May 1997 | WO |
9832412 | Jul 1998 | WO |
9913801 | Mar 1999 | WO |
0018330 | Apr 2000 | WO |
0069368 | Nov 2000 | WO |
0128459 | Apr 2001 | WO |
0149213 | Jul 2001 | WO |
0154625 | Aug 2001 | WO |
0156500 | Aug 2001 | WO |
0176510 | Oct 2001 | WO |
0236048 | May 2002 | WO |
0247575 | Jun 2002 | WO |
03047468 | Jun 2003 | WO |
06073626 | Jul 2006 | WO |
07071436 | Jun 2007 | WO |
2008042266 | Apr 2008 | WO |
08070797 | Jun 2008 | WO |
2008138584 | Nov 2008 | WO |
2009001309 | Dec 2008 | WO |
2009011866 | Jan 2009 | WO |
2009029199 | Mar 2009 | WO |
2009042196 | Apr 2009 | WO |
2009091509 | Jul 2009 | WO |
2010008548 | Jan 2010 | WO |
2010008549 | Jan 2010 | WO |
10051025 | May 2010 | WO |
10087975 | Aug 2010 | WO |
2010096176 | Aug 2010 | WO |
2010098857 | Sep 2010 | WO |
2011137531 | Nov 2011 | WO |
2012026965 | Mar 2012 | WO |
2012036741 | Mar 2012 | WO |
2016059084 | Apr 2016 | WO |
Entry |
---|
International Search Report and Written Opinion for PCT/US2018/031973, dated Oct. 19, 2018. |
Extended European Search Report for Application No. 16196712 dated May 9, 2017. |
International Search Report Application No. PCT/US2011/048963, dated Dec. 15, 2011. |
International Search Report Application No. PCT/US2011/048989, dated Dec. 15, 2011. |
International Search Report Application No. PCT/US2011/048967, dated Dec. 15, 2011. |
Ruiz, Carlos, Overview of PRE-CE Mark Transcatheter Aortic Valve Technologies, Euro PCR, dated May 25, 2010. |
International Search Report and Written Opinion for Application No. PCT/US2011/001615 dated Jul. 11, 2012. |
Commonly owned co-pending U.S. Appl. No. 13/216,124, filed Aug. 23, 2011. |
International Search Report for Application No. PCT/US2011/001597 dated Mar. 7, 2012. |
Commonly owned co-pending U.S. Appl. No. 13/234,782, filed Sep. 16, 2011. |
Commonly owned co-pending U.S. Appl. No. 13/788,820, filed Mar. 7, 2013. |
Commonly owned co-pending U.S. Appl. No. 13/212,442, filed Aug. 18, 2011. |
International Search Report for Application No. PCT/US2011/001450 dated Mar. 5, 2012. |
Australian Examination Report for Application No. 2011293898 dated Jul. 26, 2013. |
International Search Report and Written Opinion for Application No. PCT/US2013/039407 dated Feb. 10, 2014. |
International Search Report and Written Opinion for Application No. PCT/US2011/001450 dated Mar. 5, 2012. |
International Search Report and Written Opinion for Application No. PCT/US2014/064253 dated Feb. 3, 2015. |
Japanese Office Action for Application No. 2013-525891 dated May 8, 2015. |
International Search Report from PCT/US2017/063893, dated Feb. 7, 2018, 3 pages. |
Number | Date | Country | |
---|---|---|---|
20170079792 A1 | Mar 2017 | US |
Number | Date | Country | |
---|---|---|---|
61376425 | Aug 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13212442 | Aug 2011 | US |
Child | 14269684 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14269684 | May 2014 | US |
Child | 15370289 | US |